1. Home
  2. IDN vs NTRB Comparison

IDN vs NTRB Comparison

Compare IDN & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$6.68

Market Cap

101.6M

Sector

Technology

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$4.95

Market Cap

71.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDN
NTRB
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.6M
71.7M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
IDN
NTRB
Price
$6.68
$4.95
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$6.50
$13.00
AVG Volume (30 Days)
934.3K
23.4K
Earning Date
11-12-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$21,968,000.00
$2,278,321.00
Revenue This Year
$12.25
$30.17
Revenue Next Year
$11.20
$3,394.36
P/E Ratio
$691.07
N/A
Revenue Growth
14.20
12.69
52 Week Low
$2.17
$3.72
52 Week High
$7.48
$11.78

Technical Indicators

Market Signals
Indicator
IDN
NTRB
Relative Strength Index (RSI) 61.90 45.12
Support Level $6.14 $4.60
Resistance Level $6.69 $5.45
Average True Range (ATR) 0.35 0.37
MACD -0.01 0.10
Stochastic Oscillator 81.32 64.79

Price Performance

Historical Comparison
IDN
NTRB

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: